EUVIMEDOpdag EUVIMED
Open access

Sustainable Synthesis of 3‐(1 H ‐Indol‐3‐yl)propionic Acid Derivatives with Anti‐Alzheimer Activity

Fabricio Freije García, Carmen Martínez-Fernandez, Christian Griñán Ferré iD, Guadalupe García Liñares iD

ChemMedChem · 2026-07-29 · 21 (14)

DOI: 10.1002/cmdc.70395 ↗

At a glance

Journal article in ChemMedChem, published online on 2026-07-24. Written by Fabricio Freije García and 3 co-authors. Institution: Laboratorio de Biocatálisis, Departamento de Química Orgánica y UMYMFOR, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciuda…. Major MEDLINE topics: Alzheimer Disease, Indoles, Propionates, Neuroprotective Agents. 77 references. The full text is freely available in PubMed Central. Funded by: Secretaría de Ciencia y Técnica, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

A biocatalytic approach was applied to synthesizing esters and amides derived from 2‐(1 H ‐indol‐3‐yl)acetic (IAA), 3‐(1 H ‐indol‐3‐yl)propionic (IPA), and 4‐(1 H ‐indol‐3‐yl)butanoic (IBA) acids. Thirty‐seven derivatives were obtained through lipase catalysis in mild reaction conditions with good to excellent yields and a reduced environmental impact. The scope of the reaction was explored in terms of enzyme source, solvent, temperature, substrate‐to‐nucleophile and enzyme‐to‐substrate ratios, and substrate versatility. Ten representative derivatives were evaluated as potential anti‐Alzheimer's disease (AD) agents using Caenorhabditis elegans models. Among them, octyl 3‐(1 H ‐indol‐3‐yl)propanoate ( 6e ), N ‐butyl‐3‐(1 H ‐indol‐3‐yl)propanamide ( 10a ), and ( S )‐ N ‐(2‐hydroxypropyl)‐3‐(1 H ‐indol‐3‐yl)propanamide ( 13c ) emerged as the most promising candidates, demonstrating significant improvements in AD pathology, including enhanced locomotion and mitochondrial function. In addition, the obtained compounds showed no toxicity in Vero cells, making them potential lead drug candidates.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseIndolesPropionatesNeuroprotective AgentsAnimalsCaenorhabditis elegansStructure-Activity RelationshipLipaseMolecular StructureDose-Response Relationship, Drug

Author keywords

3‐(1H‐indol‐3‐yl)propionic acidAlzheimer's diseasebiocatalysislipasesynthesis

Substances

IndolesPropionates3-(indol-3-yl)propionic acidLipaseNeuroprotective Agents

Authors and institutions

  • Laboratorio de Biocatálisis, Departamento de Química Orgánica y UMYMFOR, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires, Argentina.
  • Department of Pharmacology and Therapeutic Chemistry, Institut de Neurociències-Universitat de Barcelona, Barcelona, Spain.
  • Centro de Investigación en Red, Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.

ORCID profiles: Christian Griñán Ferré, Guadalupe García Liñares

Funding

  • Secretaría de Ciencia y Técnica, Universidad de Buenos Aires
  • Consejo Nacional de Investigaciones Científicas y Técnicas

Cite

APA

Freije García, F., Martínez-Fernandez, C., Griñán Ferré, C., & García Liñares, G. (2026). Sustainable Synthesis of 3‐(1 H ‐Indol‐3‐yl)propionic Acid Derivatives with Anti‐Alzheimer Activity. ChemMedChem, 21(14). https://doi.org/10.1002/cmdc.70395

Vancouver

Freije García F, Martínez-Fernandez C, Griñán Ferré C, García Liñares G. Sustainable Synthesis of 3‐(1 H ‐Indol‐3‐yl)propionic Acid Derivatives with Anti‐Alzheimer Activity. ChemMedChem. 2026;21(14). doi:10.1002/cmdc.70395

BibTeX
@article{FreijeGarca2026,
  author = {Freije García, Fabricio and Martínez-Fernandez, Carmen and Griñán Ferré, Christian and García Liñares, Guadalupe},
  title = {Sustainable Synthesis of 3‐(1 H ‐Indol‐3‐yl)propionic Acid Derivatives with Anti‐Alzheimer Activity},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {14},
  doi = {10.1002/cmdc.70395}
}
Start for free →